Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015

World Journal of Gastroenterology

Volumn 21, Issue 42, 2015, Pages 11974-11983

  Monaco, Salvatore ^a,b   Mariotto, Sara ^a,b   Ferrari, Sergio ^a,b   Calabrese, Massimiliano ^a,b   Zanusso, Gianluigi ^a,b   Gajofatto, Alberto ^a,b   Sansonno, Domenico ^c   Dammacco, Franco ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Extra hepatic manifestations; Hepatitis C virus; Hepatitis C virus syndrome; Neurocognitive impairment; Neuropsychiatric disorders; Proton magnetic resonance spectroscopy; Sleep disorder

Indexed keywords

ANXIETY; ARTICLE; COGNITIVE DEFECT; DIFFUSION TENSOR IMAGING; EMOTIONAL STRESS; EXECUTIVE FUNCTION; FATIGUE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER FIBROSIS; MAJOR DEPRESSION; MENTAL DISEASE; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY OF LIFE; SEXUAL DYSFUNCTION; SLEEP DISORDER; VIRUS CELL INTERACTION; BRAIN; COGNITION; COGNITION DISORDERS; COMPLICATION; GENETICS; GENOTYPE; HEPACIVIRUS; HOST PATHOGEN INTERACTION; MENTAL DISORDERS; PATHOGENICITY; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGY; VIROLOGY;

BRAIN; COGNITION; COGNITION DISORDERS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; MENTAL DISORDERS; PROGNOSIS; QUALITY OF LIFE;

EID: 84947440850     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i42.11974     Document Type: Article

References (79)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362 [PMID: 2523562]
2. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of agespecific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342 [PMID: 23172780 DOI: 10.1002/hep.26141]
3. Monaco S, Ferrari S, Gajofatto A, Zanusso G, Mariotto S. HCVrelated nervous system disorders. Clin Dev Immunol 2012; 2012: 236148 [PMID: 22899946 DOI: 10.1155/2012/236148]
4. Adinolfi LE, Nevola R, Lus G, Restivo L, Guerrera B, Romano C, Zampino R, Rinaldi L, Sellitto A, Giordano M, Marrone A. Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J Gastroenterol 2015; 21: 2269-2280 [PMID: 25741133 DOI: 10.3748/wjg.v21.i8.2269]
5. Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. Semin Liver Dis 2000; 20: 143-157 [PMID: 10946420]
6. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 2007; 39: 2-17 [PMID: 16884964]
7. Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Pileri SA, Zignego AL. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 2007; 39 Suppl 1: S13-S21 [PMID: 17936215]
8. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis 2005; 5: 227-236 [PMID: 15792740]
9. Lauletta G, Russi S, Conteduca V, Sansonno L, Dammacco F, Sansonno D. Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. Medicine (Baltimore) 2013; Epub ahead of print [PMID: 23982056]
10. Ferri C, Sebastiani M, Giuggioli D, Colaci M, Fallahi P, Piluso A, Antonelli A, Zignego AL. Hepatitis C virus syndrome: A constellation of organ-and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer. World J Hepatol 2015; 7: 327-343 [PMID: 25848462 DOI: 10.4254/wjh. v7.i3.327]
11. Catanese MT, Dorner M. Advances in experimental systems to study hepatitis C virus in vitro and in vivo. Virology 2015; 479-480: 221-233 [PMID: 25847726 DOI: 10.1111/j10.1016/j.virol.2015.03.014]
12. Fletcher NF, McKeating JA. Hepatitis C virus and the brain. J Viral Hepat 2012; 19: 301-306 [PMID: 22497808 DOI: 10.1111/j.1365-2893.2012.01591.x]
13. Bonetti B, Monaco S, Giannini C, Ferrari S, Zanusso G, Rizzuto N. Human peripheral nerve macrophages in normal and pathological conditions. J Neurol Sci 1993; 118: 158-168 [PMID: 8229064]
14. Bonetti B, Scardoni M, Monaco S, Rizzuto N, Scarpa A. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia. Virchows Arch 1999; 434: 533-535 [PMID: 10394889]
15. Weissenborn K, Ennen JC, Bokemeyer M, Ahl B, Wurster U, Tillmann H, Trebst C, Hecker H, Berding G. Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut 2006; 55: 1624-1630 [PMID: 16682431]
16. Stasi C, Rosselli M, Zignego AL, Laffi G, Milani S. Serotonin and its implication in the side-effects of interferon-based treatment of patients with chronic viral hepatitis: Pharmacological interventions. Hepatol Res 2014; 44: 9-16 [PMID: 23607322 DOI: 10.1111/hepr.12116]
17. Schäfer A, Scheurlen M, Seufert J, Keicher C, Weissbrich B, Rieger P, Kraus MR. Platelet serotonin (5-HT) levels in interferontreated patients with hepatitis C and its possible association with interferon-induced depression. J Hepatol 2010; 52: 10-15 [PMID: 19897271 DOI: 10.1016/j.jhep.2009.10.007]
18. Forton DM, Hamilton G, Allsop JM, Grover VP, Wesnes K, O' Sullivan C, Thomas HC, Taylor-Robinson SD. Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. J Hepatol 2008; 49: 316-322 [PMID: 18538439 DOI: 10.1016/j.jhep.2008.03.022]
19. Stasi C, Zignego AL, Laffi G, Rosselli M. The liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis. J Viral Hepat 2011; 18: 525-532 [PMID: 21762284 DOI: 10.1111/j.1365-2893.2010.01418.x]
20. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001; 358: 38-39 [PMID: 11454379]
21. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35: 433-439 [PMID: 11826420]
22. Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 1994; 9: 347-359 [PMID: 7898401]
23. Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schüler A, Ennen JC, Ahl B, Manns MP, Böker KW. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004; 41: 845-851 [PMID: 15519659]
24. McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, Heathcote EJ. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 2005; 41: 801-808 [PMID: 15793853]
25. Bokemeyer M, Ding XQ, Goldbecker A, Raab P, Heeren M, Arvanitis D, Tillmann HL, Lanfermann H, Weissenborn K. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy. Gut 2011; 60: 370-377 [PMID: 20926642]
26. Bladowska J, Zimny A, Kołtowska A, Szewczyk P, Knysz B, Gąsiorowski J, Furdal M, Sąsiadek MJ. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation. Eur J Radiol 2013; 82: 686-692 [PMID: 23246331 DOI: 10.1016/j.ejrad.2012.11.029]
27. Bladowska J, Knysz B, Zimny A, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ. Value of perfusion-weighted MR imaging in the assessment of early cerebral alterations in neurologically asymptomatic HIV-1-positive and HCV-positive patients. PLoS One 2014; 9: e102214 [PMID: 25013963 DOI: 10.1371/journal.pone.0102214]
28. Thames AD, Castellon SA, Singer EJ, Nagarajan R, Sarma MK, Smith J, Thaler NS, Truong JH, Schonfeld D, Thomas MA, Hinkin CH. Neuroimaging abnormalities, neurocognitive function, and fatigue in patients with hepatitis C. Neurol Neuroimmunol Neuroinflamm 2015; 2: e59 [PMID: 25610883 DOI: 10.1212/NXI.0000000000000059]
29. Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall IP, Grant I, Masliah E. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis 2007; 196: 361-370 [PMID: 17597450]
30. Paulino AD, Ubhi K, Rockenstein E, Adame A, Crews L, Letendre S, Ellis R, Everall IP, Grant I, Masliah E. Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling. J Neurovirol 2011; 17: 327-340 [PMID: 21660601 DOI: 10.1007/s13365-011-0039-0]
31. Weissenborn K, Tryc AB, Heeren M, Worthmann H, Pflugrad H, Berding G, Bokemeyer M, Tillmann HL, Goldbecker A. Hepatitis C virus infection and the brain. Metab Brain Dis 2009; 24: 197-210 [PMID: 19130196 DOI: 10.1007/s11011-008-9130-5]
32. Heeren M, Weissenborn K, Arvanitis D, Bokemeyer M, Goldbecker A, Tountopoulou A, Peschel T, Grosskreutz J, Hecker H, Buchert R, Berding G. Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy. J Cereb Blood Flow Metab 2011; 31: 2199-2208 [PMID: 21629258 DOI: 10.1038/jcbfm.2011.82]
33. Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P, Wrba F, Madl C, Gangl A, Ferenci P. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002; 37: 349-354 [PMID: 12175630]
34. Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Kronfol Z, Lok AS, Padmanabhan L; HALT-C Trial Group. Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 2005; 43: 614-622 [PMID: 16237784]
35. Karaivazoglou K, Assimakopoulos K, Thomopoulos K, Theocharis G, Messinis L, Sakellaropoulos G, Labropoulou-Karatza C. Neuropsychological function in Greek patients with chronic hepatitis C. Liver Int 2007; 27: 798-805 [PMID: 17617123]
36. Huckans M, Seelye A, Parcel T, Mull L, Woodhouse J, Bjornson D, Fuller BE, Loftis JM, Morasco BJ, Sasaki AW, Storzbach D, Hauser P. The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. J Int Neuropsychol Soc 2009; 15: 69-82 [PMID: 19128530 DOI: 10.1017/S1355617708090085]
37. Lowry D, Coughlan B, McCarthy O, Crowe J. Investigating health-related quality of life, mood and neuropsychological test performance in a homogeneous cohort of Irish female hepatitis C patients. J Viral Hepat 2010; 17: 352-359 [PMID: 19758275 DOI: 10.1111/j.1365-2893.2009.01188.x]
38. Kraus MR, Schäfer A, Teuber G, Porst H, Sprinzl K, Wollschläger S, Keicher C, Scheurlen M. Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C. Hepatology 2013; 58: 497-504 [PMID: 23300053 DOI: 10.1002/hep.26229]
39. Erim Y, Tagay S, Beckmann M, Bein S, Cicinnati V, Beckebaum S, Senf W, Schlaak JF. Depression and protective factors of mental health in people with hepatitis C: a questionnaire survey. Int J Nurs Stud 2010; 47: 342-349 [PMID: 19766994 DOI: 10.1016/j.ijnurstu]
40. Zdilar D, Franco-Bronson K, Buchler N, Locala JA, Younossi ZM. Hepatitis C, interferon alfa, and depression. Hepatology 2000; 31: 1207-1211 [PMID: 10827143]
41. Kraus MR, Schäfer A, Csef H, Faller H, Mörk H, Scheurlen M. Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition. Dig Dis Sci 2001; 46: 2060-2065 [PMID: 11680576]
42. Carta MG, Hardoy MC, Garofalo A, Pisano E, Nonnoi V, Intilla G, Serra G, Balestrieri C, Chessa L, Cauli C, Lai ME, Farci P. Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy. Clin Pract Epidemiol Ment Health 2007; 3: 22 [PMID: 17956625]
43. Carta MG, Angst J, Moro MF, Mura G, Hardoy MC, Balestrieri C, Chessa L, Serra G, Lai ME, Farci P. Association of chronic hepatitis C with recurrent brief depression. J Affect Disord 2012; 141: 361-366 [PMID: 22609196 DOI: 10.1016/j.jad.2012.03.020]
44. Leutscher PD, Lagging M, Buhl MR, Pedersen C, Norkrans G, Langeland N, Mørch K, Färkkilä M, Hjerrild S, Hellstrand K, Bech P. Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. Hepatology 2010; 52: 430-435 [PMID: 20683942 DOI: 10.1002/hep.23699]
45. Knott A, Dieperink E, Willenbring ML, Heit S, Durfee JM, Wingert M, Johnson JR, Thuras P, Ho SB. Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol 2006; 101: 2254-2262 [PMID: 17032190]
46. Huckans M, Fuller B, Wheaton V, Jaehnert S, Ellis C, Kolessar M, Kriz D, Anderson JR, Berggren K, Olavarria H, Sasaki AW, Chang M, Flora KD, Loftis JM. A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C. J Psychosom Res 2015; 78: 184-192 [PMID: 25219976 DOI: 10.1016/j.jpsychores.2014.07 .020]
47. Pavlović Z, Delić D, Marić NP, Vuković O, Jašović-Gašić M. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study. Psychiatr Danub 2011; 23: 370-377 [PMID: 22075738]
48. Evon DM, Ramcharran D, Belle SH, Terrault NA, Fontana RJ, Fried MW; Virahep-C Study Group. Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study. Am J Gastroenterol 2009; 104: 2949-2958 [PMID: 19789525 DOI: 10.1038/ajg.2009.528]
49. Chapman J, Oser M, Hockemeyer J, Weitlauf J, Jones S, Cheung R. Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation. Am J Gastroenterol 2011; 106: 2123-2132 [PMID: 21826113 DOI: 10.1038/ajg.2011.252]
50. Fontana RJ, Kronfol Z, Lindsay KL, Bieliauskas LA, Padmanabhan L, Back-Madruga C, Lok AS, Stoddard AM. Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C. Am J Gastroenterol 2008; 103: 2766-2775 [PMID: 18721241 DOI: 10.1111/j.1572-0241.2008.02106.x]
51. Modabbernia A, Poustchi H, Malekzadeh R. Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature review. Hepat Mon 2013; 13: e8340 [PMID: 23550100 DOI: 10.5812/hepatmon.8340]
52. Diez-Quevedo C, Masnou H, Planas R, Castellví P, Giménez D, Morillas RM, Martín-Santos R, Navinés R, Solà R, Giner P, Ardèvol M, Costa J, Diago M, Pretel J. Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebocontrolled trial. J Clin Psychiatry 2011; 72: 522-528 [PMID: 21034680 DOI: 10.4088/JCP.09m05282blu]
53. Sarkar S, Sarkar R, Berg T, Schaefer M. Sadness and mild cognitive impairment as predictors for interferon-alpha-induced depression in patients with hepatitis C. Br J Psychiatry 2015; 206: 45-51 [PMID: 25359924 DOI: 10.1192/bjp.bp.113.141770]
54. Ferenci P, Staufer K. Depression in chronic hepatitis: the virus, the drug, or the ethnic background? Liver Int 2008; 28: 429-431 [PMID: 18339069 DOI: 10.1111/j.1478-3231.2008.01703.x]
55. Poynard T, Cacoub P, Ratziu V, Myers RP, Dezailles MH, Mercadier A, Ghillani P, Charlotte F, Piette JC, Moussalli J; Multivirc group. Fatigue in patients with chronic hepatitis C. J Viral Hepat 2002; 9: 295-303 [PMID: 12081607]
56. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27: 209-212 [PMID: 9425939]
57. Ware JE, Bayliss MS, Mannocchia M, Davis GL. Healthrelated quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 1999; 30: 550-555 [PMID: 10421667]
58. Goh J, Coughlan B, Quinn J, O'Keane JC, Crowe J. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1999; 11: 833-838 [PMID: 10514113]
59. Wessely S, Pariante C. Fatigue, depression and chronic hepatitis C infection. Psychol Med 2002; 32: 1-10 [PMID: 11883721]
60. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26: 15S-20S [PMID: 9305658]
61. Dale JK, Di Bisceglie AM, Hoofnagle JH, Straus SE. Chronic fatigue syndrome: lack of association with hepatitis C virus infection. J Med Virol 1991; 34: 119-121 [PMID: 1653818]
62. Kallman J, O'Neil MM, Larive B, Boparai N, Calabrese L, Younossi ZM. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci 2007; 52: 2531-2539 [PMID: 17406828]
63. Sarkar S, Jiang Z, Evon DM, Wahed AS, Hoofnagle JH. Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. J Hepatol 2012; 57: 946-952 [PMID: 22760009]
64. Buysse DJ. Sleep health: can we define it? Does it matter? Sleep 2014; 37: 9-17 [PMID: 24470692 DOI: 10.5665/sleep.3298]
65. Irwin MR. Sleep and infectious disease risk. Sleep 2012; 35: 1025-1026 [PMID: 22851795 DOI: 10.5665/sleep.1976]
66. Heeren M, Sojref F, Schuppner R, Worthmann H, Pflugrad H, Tryc AB, Pasedag T, Weissenborn K. Active at night, sleepy all day-sleep disturbances in patients with hepatitis C virus infection. J Hepatol 2014; 60: 732-740 [PMID: 24308991 DOI: 10.1016/j.jhep.2013.11.030]
67. Córdoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology 1998; 27: 339-345 [PMID: 9462628]
68. Mostacci B, Ferlisi M, Baldi Antognini A, Sama C, Morelli C, Mondini S, Cirignotta F. Sleep disturbance and daytime sleepiness in patients with cirrhosis: a case control study. Neurol Sci 2008; 29: 237-240 [PMID: 18810597 DOI: 10.1007/s10072-008-0973-7]
69. de Almeida CM, de Lima TA, Castro DB, Torres KL, da Silva Braga W, Peruhype-Magalhães V, Teixeira-Carvalho A, Martins-Filho OA, Malheiro A. Immunological/virological peripheral blood biomarkers and distinct patterns of sleeping quality in chronic hepatitis C patients. Scand J Immunol 2011; 73: 486-495 [PMID: 21231952 DOI: 10.1111/j.1365-3083.2011.02518.x]
70. Forton DM, Taylor-Robinson SD, Thomas HC. Cerebral dysfunction in chronic hepatitis C infection. J Viral Hepat 2003; 10: 81-86 [PMID: 12614463]
71. Foster GR. Quality of life considerations for patients with chronic hepatitis C. J Viral Hepat 2009; 16: 605-611 [PMID: 19674284 DOI: 10.1111/j.1365-2893.2009.01154.x]
72. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999; 30: 1299-1301 [PMID: 10534353]
73. Niederau C, Bemba G, Kautz A. [Socioeconomic characteristics, quality of life, and state of knowledge of patients with hepatitis C viral infection in Germany-socioeconomic aspects in hepatitis C]. Z Gastroenterol 2006; 44: 305-317 [PMID: 16625459]
74. Niederau C, Fischer C, Kautz A. [Socio-economical aspects, quality of life and state of knowledge in hepatitis B patients. Socioeconomical aspects in hepatitis B]. Z Gastroenterol 2007; 45: 355-368 [PMID: 17503314]
75. Niederau C, Bemba G, Kautz A. [Changes in socio-economics, quality of life and knowledge of patients with chronic hepatitis C during the Hepatitis Competence Net Project]. Z Gastroenterol 2008; 46: 22-33 [PMID: 18188813 DOI: 10.1055/s-2007-963534]
76. Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999; 29: 264-270 [PMID: 9862876]
77. Conversano C, Carmassi C, Carlini M, Casu G, Gremigni P, Dell' Osso L. Interferon α Therapy in Patients with Chronic Hepatitis C Infection: Quality of Life and Depression. Hematol Rep 2015; 7: 5632 [PMID: 25852845 DOI: 10.4081/hr.2015.5632]
78. Dammacco F, Sansonno D. Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. N Engl J Med 2013; 369: 1035-1045 [PMID: 24024840 DOI: 10.1056/NEJMra1208642]
79. Herzer K, Gerken G. Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of directacting antiviral agents. World J Hepatol 2015; 7: 532-538 [PMID: 25848476 DOI: 10.4254/wjh.v7.i3.532]